Solifenacin (rINN), marketed as solifenacin succinate under the trade name Vesicare, is a urinary antispasmodic of the anticholinergic class. It is used in the treatment of overactive bladder with urge incontinence. [Wikipedia]
solifenacin succinate side effects
solifenacin succinate and the other antimuscarinic drugs, such as Darifenacin and Oxybutynin chloride, which have higher affinity for muscarinic M3 receptor, are also reported to inhibit an increase in intracellular Ca2+ levels in rat salivary gland cells induced by Carbachol stimulation.